Neuroadrenerge Funktionsszintigraphie des Herzens (»Neurotransmitter Mapping«) - derzeitiger Stand

Ch. Gürtner; G. Hör

doi:10.1055/s-0038-1629561

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1991; 30(04): 111-114
DOI: 10.1055/s-0038-1629561

ÜBersichtsartikel - Review Article

Schattauer GmbH

Neuroadrenerge Funktionsszintigraphie des Herzens (»Neurotransmitter Mapping«) - derzeitiger Stand^[*]

Neuroadrenergic Functional Scintigraphy of the Heart (Neurotransmitter Mapping) - Present Status

Ch. Gürtner

¹Aus dem Zentrum der Radiologie Abteilung Nuklearmedizin (Leiter: Prof. Dr. med. G. Hör), Klinikum der Johann-Wolfgang- Goethe-Universität, Frankfurt/Main, FRG

,

G. Hör

¹Aus dem Zentrum der Radiologie Abteilung Nuklearmedizin (Leiter: Prof. Dr. med. G. Hör), Klinikum der Johann-Wolfgang- Goethe-Universität, Frankfurt/Main, FRG

› Author Affiliations

Abstract

Full Text

References

LITERATUR
1 Büll U, Hör G. Klinische Nuklearmedizin. Weinheim: Edition Medizin VCH; 1990: 168.
2 Dae MW, DeMarco T, Botvinick EH. et al. Absence of extraneuronal uptake of MIBG following cardiac transplantation. J Nucl Med 1990; 31: 792.
3 Dae MW, O’Connel JW, Botvinick EH. et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989; 79: 634-44.
4 Fagret D, Wolf J-E, Comet M. Myocardial uptake of meta-(123-I)-iodobenzylguani- dine (123-I-MIBG) in patients with myocardial infarct. J Nucl Med 1989; 15: 624-8.
4a Feistel H, Göhl K, Bachmann K, Wolf F. HMSD - Lin neues Syndrom des plötzlichen Herztods - Nachweis der sympatho- adrenergen Imbalanz im myokardialen J-123-MIBG-SPECT. Nucl-Med 1991; 30: 47.
5 Glowniak IV, Wilson RA, Turner FE, Joyce M. Effect of imipramine and cocaine on the first pass extraction fraction (EF) of MIBG in swine heart. J Nucl Med 1990; 31: 726.
6 Glowniak JV, Turner FE, Gray LL. Iodine- 123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplantation. J Nucl Med 1989; 30: 1182-91.
7 Glowniak JV, Turner FE, Gray LL, Palac RT. I-123 Metaiodobenzylguanidine (MIBG) cardiac imaging in idiopathic congestive cardiomyopathy (ICC). J Nucl Med 1987; 28: 667.
8 Grötz J, Franitzka R, Mödder G, Hossmann V. Szintigraphische Darstellung adrenerger Strukturen des Herzens mit ¹²³J- Metaiodobenzylguanidin bei Kardiomyopathie. Z Kardiol 1988; 77: 278-81.
9 Guilloteau D, Chalon S, Baulieu JL, Desplanches G. Comparison of MIBG and monoamines uptake mechanisms: Pharmacological animal and platelet studies. Eur J Nucl Med 1988; 14: 341-4.
10 Henderson EB, Corbett JR, Jansen DE, Pippin JJ. Non-invasive detection of abnormal myocardial catecholamin distribution in patients with congestive cardiomyopathy. Clin Res 1987; 35: 286.
11 Henderson EB, Kahn JK, Corbett JR. et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-9.
12 Henze E, Wieshammer S, Keck F, Clausen M, Adam WE. Dynamic lung scanning using I-123 MIBG aerosol for the selective evaluation of the sympathoadrenal system of the lungs. J Nucl Med 1990; 31: 772.
13 Hiroe M, Ohta Y, Fujita N. et al. Effects of metoprolol on cardiac adrenergic innervation using metaiodobenzylguanidine in doxorubicin (DOX)-induced myocardial damage in rats. J Nucl Med 1990; 31: 833.
14 Hiroe M, Ohta Y, Kusakabe K. et al. Cardiac tomographic assessment of regional sympathetic denervation in transient myocardial ischemia of coronary artery disease. J Nucl Med 1990; 31: 793.
15 Kline RC, Swanson DP, Wieland DH. et al. Myocardial imaging in man with I-123 metaiodobenzylguanidine. J Nucl Med 1981; 22: 129-32.
16 Merlet P, Bourguignon MH, Valette H, Agostini D. I-123 metaiodobenzylguanidine (MIBG) myocardial uptake in patients with primary hypertrophic cardiomyopathy (PHC). J Nucl Med 1989; 30: 810.
17 Nagami K, Iwanaga S, Gotoh S. et al. Regional abnormality of myocardial sympathetic nervous activity in patients with hypertrophic cardiomyopathy. J Nucl Med 1990; 31: 792.
18 Nakajiama K, Bunko H, Taki J. et al. Analysis of I-123 MIBG uptake and clearance in hypertrophic cardiomyopathy. J Nucl Med 1990; 31: 792.
19 Rabinovitch M, Rose C, Chen LF, Burgess J, Rosenthall L. Clonidine pre-treatment for the early detection of mechanical-over- load heart failure by I-123 MIBG SPECT. J Nucl Med 1989; 30: 810.
20 Richalet JP, Merlet P, Bourguignon M, Le-Trong JL, Keromes A. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia. J Nucl Med 1990; 31: 34-7.
21 Sandler MP. The expanding role of MIBG in clinical medicine. J Nucl Med 1988; 29: 1457-9.
22 Scherrer M, Agostini D, Merlet P. et al. I-123 MIBG myocardial uptake in rats in chronic hypoxia (Hx): comparison with nor- moxia (Nx). J Nucl Med 1990; 31: 726.
23 Schofer J, Spielmann R, Schuchert A, Weber K. Meta- (I-123) iodobenzyguanidin (MIBG-) scintigraphy in idiopathic dilated cardiomyopathy (idc): a noninvasive method to assess myocardial catecholamine depletion?. Circulation 1987; 76: 308.
24 Schofer J, Spielmann R, Weber K. Jod-123 Benzylguanidin (MIBG) Szintigraphie bei primär dilatativer Kardiomyopathie: Nicht invasive Methode zum Nachweis der myo- kardialen Katecholaminverarmung?. Z Kardiol 1987; 76: 17.
25 Schofer J, Schuchert A, Spielmann R, Weber K. Kardiale Jod-123-Benzylguanidin (MIBG) Szintigraphie: Befunde bei primär dilatativer Kardiomyopathie. Z Kardiol 1988; 77: 10.
26 Schwaiger M, Guibourg H, Rosenspire K. et al. Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol. J Nucl Med 1990; 31: 1352-7.
27 Slosman DO, Donath A, Alderson PhO. 131 I-metaiodobenzylguanidine and 125 I-iodoamphetamine - Parameters of lung endothelial cell function and pulmonary vascular area. Eur J Nucl Med 1989; 15: 207-10.
28 Slosman DO, Morel DR, Costabella PM, Donath A. Lung uptake of 131 I-metaiodobenzylguanidine in sheep (An in vivo measurement of pulmonary metabolic function). Eur J Nucl Med 1988; 14: 65-70.
29 Slosman DO, Polla BS, Donath A. 123 I- MIBG pulmonary removal: A biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 1990; 16: 633-7.
30 Stanton MS, Tuli MM, Radtke NL. et al. Regional sympathetic denervation after myocardial infarction in humans detected non-invasively using I-123 metaiodobenzylguanidine. J Am Coll Cardiol 1989; 14: 1519-26.
31 Stober T. Neurokardiologie. Weinheim: Edition Medizin VCH; 1990
32 Tanaka T, Aizawa T, Kato K, Nakano H, Igarashi M. Estimation of regional myocardial sympathetic neuronal function with I- 123 metaiodobenzylguanidine (MIBG) myocardial images in patients with cardiomyopathy. J Nucl Med 1989; 26: 257-61.
33 Wakasugi S, Hasegawa Y, Nakano N. Early detection and severity assessment of adriamycin (ADM)-induced cardiomyopathy with I-125 metaiodobenzylguanidine (MIBG). J Nucl Med 1990; 31: 832.
34 Wellman HN, Zipes DP. Cardiac sympathetic imaging with radioiodinated metaiodobenzylguanidine (MIBG). Progr Cardiol 1990; 03: 161-74.
35 Wolpers HG, Nguyen N, Rosenspire K. et al. Comparison of C-11 HED and I-123 MIBG for the assessment of ischemic neuronal injury in the canine heart. J Nucl Med 1990; 31: 725.

Neuroadrenerge Funktionsszintigraphie des Herzens (»Neurotransmitter Mapping«) - derzeitiger Stand[*]

Neuroadrenerge Funktionsszintigraphie des Herzens (»Neurotransmitter Mapping«) - derzeitiger Stand^[*]